TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors May 15, 1992
TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004
